Image source: The Motley Fool.
Date
April 21, 2026
Call participants
- Chief Executive Officer — Andrew Witty
- Chief Financial Officer — Wayne DeVeydt
- Chief Executive Officer, UnitedHealthcare — Tim Noel
- Chief Executive Officer, Optum — Patrick Conway
- President, UnitedHealthcare — Krista Nelson
- President, Pharmacy Care Services (OptumRx) — John Rex
- President, Optum Financial Services — Bobby Hunter
- Chief Digital and Technology Officer — Sandeep Dadlani
Takeaways
- Total revenues — $111.7 billion, up 2% year over year, driven by disciplined pricing actions and changes in member mix.
- Adjusted earnings per share (EPS) — $7.23, exceeding internal plan expectations and supported by strong quality metrics including robust cash flows and reserves.
- Medical care ratio (MCR) — 83.9%, improved from 84.8% last year due to pricing discipline, medical cost management, and favorable reserve development.
- Operating cost ratio — 13.8%, reflecting timing of operational, technology, AI, and customer experience investments, alongside $900 million in incentive compensation (versus $35 million prior year).
- Operating cash flow — $8.9 billion, or 1.4 times net income, enabling reduction of debt-to-capital ratio to 42.9%, progressing toward a year-end target of 40%.
- Domestic membership — 49.1 million, compared to 49.8 million at the end of last year, reflecting membership trends and market actions.
- Medicare membership update — Anticipated full-year contract decline is now centered around a drop of 1.3 million members, in line with previous guidance.
- Medicaid outlook — Management expects ongoing membership attrition and negative margins throughout the year, with modest margin improvements possible beginning in 2027.
- ACA membership — Individual ACA segment is expected to contract by approximately one-third this year; focus is on bronze and gold tiers with member mix and utilization aligned to plan.
- OptumHealth adjusted earnings — $1.3 billion, reflecting benefits from prior period reserve development and operational improvements, compared against a full-year target of $1.575 billion midpoint.
- Share repurchases — At least $2 billion to deploy by the end of the second quarter, accelerated from original guidance, due to current intrinsic value discount in share price.
- AI-related investment — Approximately $1.5 billion budgeted for AI initiatives in 2026, with a 2:1 return targeted on internal use cases over the coming years.
- Prior authorization automation — 95% of requests now electronic; 50% processed in real time; 90% approved within one business day; goal to reduce medical prior authorizations by 30% or more by year end.
- Digital engagement — Nearly 50% of members using UHC digital tools (up 42% over two years); 73 million digital visits in the first quarter; over 80% of consumer contacts now digital.
- OptumRx new clients — Onboarded more than 800 new clients, while reducing call center volume by 25% via digital and AI-enabled self-service tools.
- Operating segment weighting — UnitedHealthcare and OptumHealth earnings are weighted towards the first half (>75% first-half for UnitedHealthcare); OptumInsight and OptumRx earnings expected to be roughly 60% in the second half of the year.
Need a quote from a Motley Fool analyst? Email [email protected]
Risks
- Medicaid margins remain negative due to high medical cost trend and insufficient state funding, with management stating, “We continue to expect membership attrition and negative margins in 2026 in light of continuing high trend and insufficient funding, with modest margin improvements beginning in 2027.”
- Ongoing legislative developments, including Tennessee’s retail pharmacy-related legislation, are expected to negatively impact access for nearly 150,000 specialized patients per management.
Summary
UnitedHealth Group (UNH +9.13%) reported improved first quarter performance across all business segments, driven by realized pricing, operational improvements, and digital transformation initiatives. Management intensified its U.S.-centric strategy by completing the exit from non-U.S. businesses and refreshing half of its top 100 leadership roles, while initiating significant governance enhancements and committing $400 million from business divestiture proceeds to community health initiatives. The updated full-year outlook calls for adjusted EPS above $18.25, reflecting strong first half momentum and a prudent approach to remaining execution risks, with earnings and medical cost seasonality expected to follow established intra-year patterns. Strategic priorities include scaling AI investment and commercialization through OptumInsight, deploying new partnerships in rural healthcare, and implementing automation to improve prior authorization and member/provider engagement. Segmentally, OptumHealth reported favorable contract restatements and operational gains and will see the majority of full-year earnings in the first half; OptumRx and OptumInsight results are expected to strengthen later in the year as legacy offerings are replaced by AI-first solutions and new client onboarding matures.
- Costs related to $400 million in UnitedHealth Foundation allocations were fully funded by gains realized within OptumInsight following the divestiture of the U.K. business.
- Management stated, “We expect a conservative 2:1 return on these programs over the next few years, many paying back within the next 12 to 18 months.”
- Following board-level governance changes, a public responsibility committee and a new lead independent director have been established.
- Optum Financial Services agreed to acquire Allegis Technologies, with the deal expected to be accretive by 2027.
- OptumHealth’s value-based care model demonstrated a 35% reduction in skilled nursing admissions in the West region, with a 12% year-over-year increase in patient-facing hours after operational standardization in 70% of settings.
- UnitedHealthcare will accelerate rural hospital payments by 50% and exempt rural health care providers from most prior authorizations, aiming to bolster rural access and provider financial stability.
- OptumRx’s “PreCheck” prior authorization tool reduced prescription approval time from over eight hours to less than thirty seconds, achieving a 68% reduction in denials due to missing information and an 88% reduction in appeals.
- Chief Financial Officer Wayne DeVeydt reported that net prior period development (PYD) benefited quarterly results by “a little bit north of $500 million.”
- Final disposition of assets and prior year restructuring actions resulted in a $50 million net negative impact to first quarter adjusted results, with a $525 million gain from the successful sale of the U.K. business partly offset by foundation funding.
Industry glossary
- Medical care ratio (MCR): The ratio of total medical costs paid to total premium revenue collected, indicating efficiency in managing health plan expenses.
- Adjusted earnings per share (EPS): Earnings per share figure excluding selected nonrecurring or non-operational items to provide a normalized view of operating performance.
- PDR (Premium Deficiency Reserve): A reserve established when expected future claims on a block of business exceed anticipated future premiums.
- Prior period development (PYD): Adjustments to reserves based on updated realization of claims obligations initially estimated in previous reporting periods.
- OptumInsight: The UnitedHealth Group business segment providing healthcare data analytics, technology, consulting, and managed services to external organizations and internal segments.
- OptumRx: The pharmacy benefit management (PBM) business unit within Optum, responsible for prescription fulfillment, formulary management, and related drug benefit administration.
- Value-based care: A healthcare delivery model that compensates providers based on patient health outcomes and cost efficiency rather than service volume.
- HCC (Hierarchical Condition Category): A risk adjustment coding system used to determine expected annual costs for Medicare Advantage and other risk-based contracts.
- Medicare Advantage (MA): Federal health insurance plan in which private insurers contract with Medicare to provide Part A and B benefits, frequently through managed care arrangements.
Full Conference Call Transcript
Andrew Witty: Good morning, and thank you for joining us today. The first quarter unfolded largely as expected, reflecting actions taken in the past several months to drive consistent performance across each business. The quarter saw continued progress in advancing our organization, performance culture, and better business practices. All of our major business segments exceeded plan for the quarter. At UnitedHealthcare, pricing is improving relative to elevated health care cost trends, and affordability initiatives are generating positive momentum. At OptumHealth, operational improvements continue to take hold as we more deeply embed disciplined, integrated, value-based care practices market by market. OptumInsight is seeing increased market interest with its AI-first enterprise approach.
Tim Noel and Patrick Conway will discuss these efforts in more detail in a minute. We are encouraged by the way the year has started. We remain grounded in the need for consistent execution in managed care fundamentals, and on a strategy to help build an integrated, value-based health system that together makes things better and simpler for care providers, patients, and customers. We are investing in AI-enabled modernization. While early, these capabilities are already improving experiences for consumers and care providers, increasing productivity, and reducing administrative burden. The application of technology has long been foundational to how this enterprise operates, and how we can help others across the health system improve their operations through OptumInsight.
We remain on track to invest nearly $1.5 billion in AI-related initiatives in 2026. I hope our conversation today gives you a sense of the momentum building in our company and the steps we have taken to strengthen the enterprise and position it for long-term success. We have refocused the organization squarely on U.S. healthcare, exiting non-U.S. businesses. We have refreshed nearly half of our top 100 leadership roles. Our accelerated technology and AI investments are showing meaningful potential, and we are actively evolving business practices in areas such as data and processing interoperability and speed, pharmacy practices, prior authorization, product and reporting transparency, and management practices more broadly.
At the corporate level, we strengthened governance by creating a public responsibility committee of the Board, naming a new lead independent director and new committee chair, adding a new independent director, and accelerating our board recruiting process. And we have redoubled community engagement and support, with renewed focus and resources to the UnitedHealth Foundation, and an expanding commitment to improving rural healthcare, expanding the healthcare workforce, strengthening maternal and children’s health, addressing the challenges of behavioral health, and more. We strive to be an organization of people proud to work for and with. These efforts and others will remain central to those goals.
See More
